Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026)
Vir Biotechnology (VIR) reported Return on Assets [ROA] of -22.47% for Q2 2026, up 21.55 percentage points from -44.01% a year earlier and up 21.18 percentage points from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2025, Vir Biotechnology posted Return on Assets [ROA] of -36.47%, down 5.01 percentage points from FY2024.
- Return on Assets [ROA] has declined for four consecutive years, though with a five-year change of +5.27 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -31.46% in FY2024 (-5.41 pp), -26.06% in FY2023 (-47.75 pp), 21.69% in FY2022 (-15.11 pp) and 36.80% in FY2021 (+78.54 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q2 2023.
- Year over year, Return on Assets [ROA] gained in 1 of the last eight quarters, with an average year-over-year change of -4.83 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2022 (a gain of 88.24 percentage points); the low point was Q3 2023 (a drop of 71.01 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -43.65% (Q1 2026), -43.32% (Q4 2025) and -45.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | -22.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.47% |
| Mar 31, 2026 | -43.65% |
| Dec 31, 2025 | -43.32% |
| Sep 30, 2025 | -45.18% |
| Jun 30, 2025 | -44.01% |
| Mar 31, 2025 | -42.69% |
| Dec 31, 2024 | -36.03% |
| Sep 30, 2024 | -33.67% |
| Jun 30, 2024 | -27.89% |
| Mar 31, 2024 | -29.06% |
| Dec 31, 2023 | -31.04% |
| Sep 30, 2023 | -28.01% |
| Jun 30, 2023 | -10.67% |
| Mar 31, 2023 | -5.26% |
| Dec 31, 2022 | 18.76% |
| Sep 30, 2022 | 43.00% |
| Jun 30, 2022 | 39.15% |
| Mar 31, 2022 | 50.24% |
| Dec 31, 2021 | 33.41% |
| Sep 30, 2021 | -9.02% |
API Access
Vir Biotechnology Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();